The project is being implemented in two phases: vaccine development and distribution
LENZELTA® is administered in two doses during the dry-off period, a stage when cows are particularly vulnerable to infection.
Since 2021, highly pathogenic avian influenza H5 has caused unprecedented losses worldwide.